Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ORAPRED

PREDNISOLONE SODIUM PHOSPHATE

Standard Dose
EQ 15MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ORAPRED is listed in Drugs@FDA under application 075117 (ANDA).

Marketing status: Discontinued Active ingredient PREDNISOLONE SODIUM PHOSPHATE Form and strength SOLUTION;ORAL - EQ 15MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor CONCORDIA PHARMS INC Submission history Latest submission status date: 2005-06-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview ORAPRED is listed in Drugs@FDA under application 075117 (ANDA). Marketing status: Discontinued Active ingredient PREDNISOLONE SODIUM PHOSPHATE Form and strength SOLUTION;ORAL - EQ 15MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor CONCORDIA PHARMS INC Submission history Latest submission status date: 2005-06-16 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.